PDCD1 and hepatocellular carcinoma: High levels of exosomal circTMEM181 sponged miR-488-3p and upregulated CD39 expression in macrophages, synergistically promoting the activation of the adenosine pathway by cooperating with CD73 expression, thereby leading to T cell exhaustion and resistance to anti-PD-1 therapy in HCC patients (131).